Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Ye, Xin  [Clear All Filters]
2024
Sang J, Liu P, Wang M, Xu F, Ma J, Wei Z, Ye X. Stem-like CD8 T cells in stage I lung adenocarcinoma as a prognostic biomarker: A preliminary study. J Cancer Res Ther. 2024;20(2):669-677.
2023
Cheng Y, Chen H, Duan P, Zhang H, Yu Y, Yu J, Yu Z, Zheng L, Ye X, Pan Z. Early depletion of M1 macrophages retards the progression of glucocorticoid-associated osteonecrosis of the femoral head. Int Immunopharmacol. 2023;122:110639.
2022
Chen D, Wang T, Ye X, Xu X, Xia W, Fu Y. Generation of induced pluripotent stem cell line derived from FNAIT patient with CD36 deficiency mutations. Stem Cell Res. 2022;61:102749.
2020
Wu Y, Chen D, Xu X, Mai M, Ye X, Li C, Santoso S, Xia W, Fu Y. Hydrops fetalis associated with anti-CD36 antibodies in fetal and neonatal alloimmune thrombocytopenia: Possible underlying mechanism. Transfus Med. 2020.
Han X, Ni J, Wu Z, Wu J, Li B, Ye X, Dai J, Chen C, Xue J, Wan R, et al. Myeloid-specific dopamine D2 receptor signaling controls inflammation in acute pancreatitis via inhibiting M1 macrophage. Br J Pharmacol. 2020.
2015
Lu H, Clauser KR, Tam WLeong, Fröse J, Ye X, Eaton ENg, Reinhardt F, Donnenberg VS, Bhargava R, Carr SA, et al. Addendum: A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat Cell Biol. 2015;17(12):1607.